Lalvand, Atefeh, Masoumi, Mahlasadat, Akiash, Nehzat, Azizidoost, Shirin, Abbaspour, Somayeh (2025). Stromal/stem Cell-derived Exosomes: Therapeutic Approach for Heart Failure. Shahid Sadoughi University of Medical Sciences- Journal Management System, 1(3), 216-223. doi: 10.22034/jrb.2025.528.1021
Atefeh Lalvand; Mahlasadat Masoumi; Nehzat Akiash; Shirin Azizidoost; Somayeh Abbaspour. "Stromal/stem Cell-derived Exosomes: Therapeutic Approach for Heart Failure". Shahid Sadoughi University of Medical Sciences- Journal Management System, 1, 3, 2025, 216-223. doi: 10.22034/jrb.2025.528.1021
Lalvand, Atefeh, Masoumi, Mahlasadat, Akiash, Nehzat, Azizidoost, Shirin, Abbaspour, Somayeh (2025). 'Stromal/stem Cell-derived Exosomes: Therapeutic Approach for Heart Failure', Shahid Sadoughi University of Medical Sciences- Journal Management System, 1(3), pp. 216-223. doi: 10.22034/jrb.2025.528.1021
Lalvand, Atefeh, Masoumi, Mahlasadat, Akiash, Nehzat, Azizidoost, Shirin, Abbaspour, Somayeh Stromal/stem Cell-derived Exosomes: Therapeutic Approach for Heart Failure. Shahid Sadoughi University of Medical Sciences- Journal Management System, 2025; 1(3): 216-223. doi: 10.22034/jrb.2025.528.1021

Stromal/stem Cell-derived Exosomes: Therapeutic Approach for Heart Failure

Regenerative Biomedicine
Volume 1, Issue 3, Summer 2025, Pages 216-223    PDF (912.64 K)
Document Type: Mini-Review
DOI: 10.22034/jrb.2025.528.1021
Authors
Atefeh Lalvand1; Mahlasadat Masoumi* 1; Nehzat Akiash1; Shirin Azizidoost2; Somayeh Abbaspour3
1Cardiologist, Fellowship of Advanced Echocardiography, Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3Cardiologist, Fellowship of Heart Failure and Cardiac Transplantation, Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Abstract
Heart failure remains a notable clinical and public health challenge worldwide. Current treatment modalities have shown limited success in reducing morbidity and mortality rates, highlighting the urgent need for alternative and novel therapeutic approaches. Growing evidence suggests that stem cell-derived exosomes, membrane-bound extracellular vesicles, are emerging as promising candidates for treating heart failure. Exosome released from mesenchymal stem cells and induced pluripotent stem cells (iPSCs) have demonstrated cardioprotective, immunomodulatory, and reparative effects. key advantages include targeted delivery, reduced immunogenicity, decreased tumor formation risk, and improvement storage and transportation feasibility. Despite their promise, challenges such as low production yield, stability concerns, and efficient delivery methods remain. standard methods for exosome isolation and characterization is needed. This mini-review summarizes stem cell-derived exosomes with potential applications in heart failure. Modifying exosome contents by regulating specific microRNA (miRNAs) can modulate communication between cardiac cells, often resulting in improved cardioprotection through various signaling pathways. The underling mechanism of these pathways encompasses enhancing angiogenesis, apoptosis inhibition, and fibrosis reduction.
Keywords
Cardiac Repair; Embryonic Stem Cells (ESCs); Exosome; Mesenchymal Stem Cells (MSCs); Pluripotent Stem Cells (PSCs)
Statistics
Article View: 227
PDF Download: 170